- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05014984
WOOP VA: Promoting Weight Management in Primary Care (WOOP VA)
WOOP VA: Mental Contrasting With Implementation Intentions to Promote Weight Management in Primary Care
Study Overview
Status
Conditions
Intervention / Treatment
- Behavioral: Information About Diet, Physical Activity, and Weight Management (Baseline Visit - 10 minutes): All
- Behavioral: mental contrasting with implementation intentions
- Behavioral: Telephone MCII Check-ins (30 minutes at 3 days, 4 weeks, and 2 months after baseline visit)
- Behavioral: telephone-delivered, telehealth-delivered, and or in-person MOVE! or TeleMOVE!
Detailed Description
Background: Approximately 40% of Veterans have obesity. Intensive weight management programs such as MOVE! promote clinically significant weight loss, but only 3-7% of eligible Veterans attend. Low enrollment and high attrition are due to obstacles such as travel, cost, and motivation. Developed through over 20 years of research, Mental Contrasting with Implementation Intentions (MCII) is a novel, evidence-based intervention to increase motivation and behavior change. MCII has been shown to increase physical activity and consumption of fruits and vegetables and promote weight loss, and the research team recently demonstrated that MCII is feasible and acceptable to Veterans for weight management. However, has not been tested adequately within primary care nor demonstrated weight loss in Veterans. The investigators propose to evaluate the efficacy and implementation of MCII for behavior change and weight loss in Veterans within primary care when combined with the VA MOVE! Program.
Significance/Impact: This proposal aligns with the VA HSRD "primary care practice and management of complex chronic diseases" funding priority. Primary care providers and PACT members do not provide sufficient counseling to increase engagement with the MOVE! Program. MCII can be taught by lay educators and can be delivered in conjunction with MOVE! and other weight management treatments.
Innovation: MCII is innovative in its use of imagery, ease of delivery by lay educators, novel mechanisms of action (via non-conscious motivational and cognitive processes), and ability to be combined with other programs. Veterans can practice MCII on their own in under 10 minutes. MCII uses a standardized, 4-step imagery procedure called WOOP that can be taught in 30 minutes. Veterans can then continue to use WOOP regularly, with the assistance of a WOOP App and website containing video-, audio-, and paper-based tools. This study will be the first randomized controlled trial of MCII within primary care and the first RCT to test the efficacy and implementation of MCII for weight management when combined with MOVE! in Veterans.
Specific Aims: 1. Compare the impact of MCII + MOVE! vs. MOVE! alone on percent weight change and waist circumference at 6 and 12 months. 2. Compare the impact of MCII + MOVE! vs. MOVE! alone on MOVE! attendance, physical activity, and healthy eating at 6 and 12 months. 3. Evaluate implementation of MCII. The investigators will use the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework7,8 to evaluate implementation barriers, facilitators, and outcomes of MCII.
Methodology: The investigators will randomize 366 Veterans within primary care to either MCII + telephone-delivered MOVE! (intervention) vs. telephone-delivered MOVE! alone (control) at the Manhattan VA. At 6 and 12 months, participants will return to the clinic for a study visit where weight, diet, and physical activity will be assessed in both groups. The investigators will use intention-to-treat analyses.
Implementation/Next Steps: MCII is designed to be easily implemented in a variety of settings and for a variety of behaviors. Freely available online training materials will facilitate implementation. To guide future implementation and policy change, the research team will present data from Aim 3 implementation analyses and obtain input from Veteran stakeholders as well as local VA and NCP leaders. If found to be efficacious, the investigators will conduct hybrid effectiveness/implementation studies of MCII in a multi-site study.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Melanie R Jay, MD MS
- Phone Number: (212) 686-7500
- Email: Melanie.Jay@va.gov
Study Contact Backup
- Name: Sandra Wittleder, PhD
- Phone Number: (646) 992-0223
- Email: sandra.wittleder@nyulangone.org
Study Locations
-
-
New York
-
New York, New York, United States, 10010-5011
- Recruiting
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
-
Contact:
- Melanie R Jay, MD MS
- Phone Number: 212-686-7500
- Email: Melanie.Jay@va.gov
-
Contact:
- Leslie Dowers, MSA
- Phone Number: (718) 630-3645
- Email: leslie.dowers@va.gov
-
Principal Investigator:
- Melanie R. Jay, MD MS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18-70 (this age range represents MOVE! eligibility);
- The most recent BMI of 30kg/m2 (with or without obesity-associated comorbidities) OR a BMI of 25kg/m2 with obesity-associated condition (heart diseases, hyperlipidemia, hypertension, cancer, diabetes, stroke, or osteoarthritis);
- at least 1 prior PCP visit in the past 24 months; access to a telephone; ability to travel to Manhattan VA for in-person evaluations at baseline, 6 and 12 months;
- desire to lose weight (Using 1-10 scale used in PI's other studies; minimum of 5/10);
- willingness to enroll in the MOVE! program.
Exclusion Criteria:
- Non-Veterans;
- a documented current history of active psychosis or other cognitive issues via ICD-10 codes;
- Diagnosed with Parkinson's disease and/or severe arthritis;
- participating in a weight management study in the past year;
- taking an FDA-approved weight loss medication; Bupropion-naltrexone (Contrave) Liraglutide (Saxenda) Orlistat (Xenical)/alli Phentermine-topiramate (Qsymia) Phentermine Topiramate Lorcaserin / Belviq glucagon-like peptide 1 (GLP-1) agonists:
Diabetes drugs in the GLP-1 agonists class include:
Dulaglutide (Trulicity) Exenatide extended release (Bydureon) Exenatide (Byetta) Semaglutide (Ozempic) Semaglutide (Rybelsus) Liraglutide (Victoza) Lixisenatide (Adlyxin) Metformin to lose weight not for your diabetes;
- pregnancy;
- PCP stating that Veteran should not participate.
- Seeing a dietitian or MOVE! Program attendance more than 3 times in the past year.
- Hospitalization within 90 days of enrollment.
- Anyone who is included in Dr. Jose Aleman weight management clinic
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Telephone Delivered MOVE!
During the baseline visit, Veterans randomized to the control arm will receive only the standard information about MOVE!, diet, and physical activity delivered by the same lay educators.
They will not learn the WOOP technique nor receive telephone follow up as detailed below.
While we considered having an attention control with the same amount of contact, we decided that the study would be more pragmatic and findings would be more relevant to real-world practice if the control arm followed standard patient education and referral strategies.
Data collection during study visits will be at the same timepoints in both arms.
|
All participants will receive handouts that they review with a lay educator on weight management, adapted from the educational materials developed for our FIReWoRk Study.Topics include losing weight at a healthy rate, setting a 6-month weight loss goal of 5-10%, limiting sugar-sweetened beverages and portion sizes, making better choices when eating at restaurants, self-monitoring diet and weight, and participating in at least moderate-intensity physical activities.
MOVE! is a national VA weight management and health promotion program to improve the quality of life of Veterans.6,75
This effective program encourages healthy eating behavior and increased physical activity.
MOVE! will be delivered via telephone (16 sessions) by existing staff consistent with national MOVE! program guidelines.
The program has 16 modules and will offered weekly, but Veterans will be able to make up sessions at their own pace if they miss one.
MOVE! staff use the MOVE! facilitator guide that provides instruction on delivering the program via telephone.
Update as of 11-2023, the New York Harbor VA paused their offering of telephone-delivered MOVE!.
Participants in both arms are offered the in-person or video-delivered MOVE! program.
For participants who do not want or are unable to attend group-based MOVE!, they are offered TeleMOVE!.
|
Experimental: Mental Contrasting with Implementation Intentions (WOOP) plus MOVE!
At the baseline visit, a lay educator will teach the WOOP technique in-person using protocols adapted from our prior work.12
After, to support WOOP practice, the lay educator will schedule and provide 3 follow-up telephone check-ins with the Veteran.
This arm will also receive telephone-delivered MOVE!
|
All participants will receive handouts that they review with a lay educator on weight management, adapted from the educational materials developed for our FIReWoRk Study.Topics include losing weight at a healthy rate, setting a 6-month weight loss goal of 5-10%, limiting sugar-sweetened beverages and portion sizes, making better choices when eating at restaurants, self-monitoring diet and weight, and participating in at least moderate-intensity physical activities.
To deliver MCII, Dr. Oettingen developed a step-wise procedure called WOOP (Wish, Outcome, Obstacle, Plan; Figure 1).36
In a quiet setting, patients identify an important wish (e.g., losing weight) and then name and vividly imagine the best outcome (e.g., feeling healthier).
Next, they name a current internal obstacle (e.g., urge to eat when feeling stressed) and try to vividly imagine their experience when they encounter this obstacle.
Finally, they address their obstacle with an if-then plan specifying when, where, and how to overcome it (e.g., "If I have the urge to eat when feeling stressed, I will go for a walk)" and then imagine themselves experiencing the obstacle and carrying out the action of surmounting it.
To facilitate use of the WOOP technique, Dr. Oettingen developed a free, publicly available WOOP app
Other Names:
The lay educator will review and practice the WOOP technique based on protocols from prior studies.12
To probe Veterans' comprehension, the lay educator will ask for their four steps and ask about their WOOP use and experiences.
If needed, the lay educator will help the Veteran to create a new WOOP for the next month and address any questions and concerns about using WOOP.
MOVE! is a national VA weight management and health promotion program to improve the quality of life of Veterans.6,75
This effective program encourages healthy eating behavior and increased physical activity.
MOVE! will be delivered via telephone (16 sessions) by existing staff consistent with national MOVE! program guidelines.
The program has 16 modules and will offered weekly, but Veterans will be able to make up sessions at their own pace if they miss one.
MOVE! staff use the MOVE! facilitator guide that provides instruction on delivering the program via telephone.
Update as of 11-2023, the New York Harbor VA paused their offering of telephone-delivered MOVE!.
Participants in both arms are offered the in-person or video-delivered MOVE! program.
For participants who do not want or are unable to attend group-based MOVE!, they are offered TeleMOVE!.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight Change
Time Frame: Baseline, 6 and 12 months
|
The research team will measure weight using a standardized protocol, taking the average of 2 weights in pounds, rounded to the nearest 0.1lb.
|
Baseline, 6 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Waist Circumference change
Time Frame: Baseline, 6 and 12 months
|
The RA will use an inelastic tape scaled in cm to measure the participant's waist circumference twice at the peak of the iliac crests, taking the average of the 2 measures rounded to the nearest 0.25cm.
|
Baseline, 6 and 12 months
|
Healthy Eating Index change
Time Frame: baseline, 6 and 12 months
|
The HEI-2015 is a diet quality index that measures alignment with the 2015-2020 Dietary Guidelines for Americans.
To measure dietary intake at each time point, we will use an automated, cost-effective and valid 24-hour dietary recall instrument for measuring diet quality.
The web-based Automated Self-Administered 24-Hour Recall (ASA24-2020), developed by the National Cancer Institute and first released in 2009 was modeled after the US Department of Agriculture's interviewer- administered Automated Multiple-Pass Method (AMPM).
To limit participant burden, participants will perform one weekday measurement (self-administered in person with staff available to answer questions as needed) and one weekend measurement (self-administered at home).
While at least three 24-hour recall measurements are considered the gold standard, two measurements are valid.
If we cannot obtain a weekend measure, we will obtain two weekday measures and account for this in the analysis.
|
baseline, 6 and 12 months
|
Physical Activity--Weekly minutes of Moderate to Vigorous Physical Activity (MVPA)
Time Frame: Baseline, 6 and 12 months
|
The research team will use the ActiGraph Link (GT9X) accelerometer to objectively measure PA during a 7-day period.
During an initial enrollment visit, RAs will place the Link monitor on the participant's non-dominant wrist and instruct the participant to measure PA for 24 hours a day for 7 days, except when swimming and bathing, and to return the monitor at the baseline visit two weeks later.
We will use accelerometer data to report weekly minutes of MVPA.
|
Baseline, 6 and 12 months
|
MOVE! Attendance change
Time Frame: Baseline, 6 and 12 months
|
The MOVE! program coordinator records MOVE! attendance as a date of service in the CPRS electronic health record.
We will refer to this record to verify the number of MOVE! sessions completed
|
Baseline, 6 and 12 months
|
Change in Self Reported Physical Activity
Time Frame: Baseline, 6 and 12 months
|
Self-reported weekly minutes of MVPA will be measured via the Global Physical Activity Questionnaire (GPAQ).
|
Baseline, 6 and 12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Melanie R. Jay, MD MS, Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIR 20-153
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted
Clinical Trials on Information About Diet, Physical Activity, and Weight Management (Baseline Visit - 10 minutes): All
-
Australian National UniversityUniversity of Sydney; Commonwealth Scientific and Industrial Research Organisation... and other collaboratorsCompletedDepressive Disorder | DepressionAustralia
-
University of PeshawarUniversity of Agriculture, PeshawarCompletedMetabolic DiseasePakistan